Advertisement

Topics

GLAUKOS CORPORATION Company Profile

08:27 EDT 26th September 2018 | BioPortfolio

Glaukos Corporation is committed to transforming glaucoma therapy. To this end, Glaukos is bypassing anatomical impediments and treatment conventions to develop treatments that restore natural physiologic outflow as a foundation of significant, steady and sustained glaucoma management.
Today, we are at the beginning with an innovative micro technology. In collaboration with our clinician partners, we are building technology towards a safer and more effective treatment for preserving vision in patients with primary open-angle glaucoma.

Location

26051 Merit Circle Suite 103
Laguna Hills
California
92653
United States of America

Contact

Phone: 949.367.9600
Fax: 949.367.9984
Email: contact@glaukos.com


News Articles [107 Associated News Articles listed on BioPortfolio]

Glaukos files patent lawsuit against Ivantis

Glaukos Corporation filed a patent infringement lawsuit against Ivantis Inc., according to a company press release.Filed in the U.S. District Court for the Central District of California, Southern Div...

Glaukos Enters Pharmaceutical Development Agreement With D. Western Therapeutics Institute

NewsUnder the agreement, Glaukos and DWTI will conduct joint research for the development of novel intraocular products for the treatment of glaucoma using compounds from DWTI’s proprietary ROCK inh...

Glaukos, D. Western Therapeutics ally in glaucoma

Glaukos Corp. and Japanese biotech D. Western Therapeutics Institute Inc. (DWTI) are teaming up to create new glaucoma therapies.

Glaukos and DWTI announce development agreement

Glaukos Pharmaceutical, an ophthalmic medical technology and pharmaceutical company, and D. Western Therapeutics Institute (DWTI), a Japanese biotechnology company, have announced an agreement.

Glaukos Announces Participation in Bank of America Merrill Lynch 2018 Health Care Conference

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustai...

FDA OKs Glaukos' trabecular micro-bypass system

Glaukos' iStent inject trabecular micro-bypass system has received approval from the FDA.  -More- 

Glaukos Corporation to Release First Quarter 2018 Financial Results after Market Close on May 9

Conference Call and Webcast Scheduled for 1:30 p.m. PDT Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercializa...

Glaukos Corporation to Release Second Quarter 2018 Financial Results after Market Close on August 2

Conference Call and Webcast Scheduled for 1:30 p.m. PDT Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the ...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results.

Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in the trabecular meshwork (iStent®, iStent I...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Investigation of the Glaukos® Trabecular Micro-Bypass System, Model iS3, in Subjects With Refractory Glaucoma

Prospective, multi-center, single-arm clinical trial to evaluate the safety and effectiveness of the Glaukos® Trabecular Micro-Bypass System Model iS3 (three stents per study eye) in subj...

Investigation of the iStent Inject® Devices in Open-Angle Glaucoma

The aim of this study is to evaluate the safety and intraocular pressure (IOP) lowering effect of two iStent inject devices in combination with cataract surgery in patients with mild-to-mo...

A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma Subjects

The purpose of this study is to evaluate the safety and efficacy of the iStent trabecular micro-bypass stent in reducing intraocular pressure (IOP) in refractory open-angle glaucoma subjec...

A Comparison of Cataract Surgery Alone and Cataract Surgery With iStent

Glaucoma is the commonest cause of irreversible blindness in the world. Treatment centres around lowering intraocular pressure (IOP) and typically includes medication (least invasive), las...

Companies [175 Associated Companies listed on BioPortfolio]

GLAUKOS CORPORATION

Glaukos Corporation is committed to transforming glaucoma therapy. To this end, Glaukos is bypassing anatomical impediments and treatment conventions to develop treatments that restore natural physiol...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

NEC Corporation of America

NEC Corporation of America (NEC) is a leading technology integrator providing solutions that improve the way people work and communicate. NEC delivers integrated Solutions for Soc...

Hot Spring Spas

Hot Spring Spas is the world’s leading brand of hot tubs and is sold through a network of more than 700 independent dealers throughout North America and 70 countries around t...

More Information about "GLAUKOS CORPORATION" on BioPortfolio

We have published hundreds of GLAUKOS CORPORATION news stories on BioPortfolio along with dozens of GLAUKOS CORPORATION Clinical Trials and PubMed Articles about GLAUKOS CORPORATION for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GLAUKOS CORPORATION Companies in our database. You can also find out about relevant GLAUKOS CORPORATION Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record